Market Cap (In AUD)
299.62 Million
Revenue (In AUD)
5.31 Million
Net Income (In AUD)
-7.18 Million
Avg. Volume
172.01 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.35-1.27
- PE
- -
- EPS
- -
- Beta Value
- 0.855
- ISIN
- AU000000OCC6
- CUSIP
- Q71504106
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Paul Frederick Anderson
- Employee Count
- -
- Website
- https://orthocell.com
- Ipo Date
- 2014-08-12
- Details
- Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
More Stocks
-
PLBCPlumas Bancorp
PLBC
-
JKS
-
0QUS
-
5384Fujimi Incorporated
5384
-
BGAOYProximus PLC
BGAOY
-
COFFEEDAYCoffee Day Enterprises Limited
COFFEEDAY
-
5ZM
-
000828